The Danish drugmaker is collaborating with Vivtex, cofounded by billionaire Robert Langer, to quickly iterate oral versions of successors to Ozempic and Wegovy.Ozempic has been a household name for less than half a decade, but it and other GLP-1 drugs are already a blockbuster pharmaceutical category, estimated to reach $150 billion globally by 2030. Between […]
